Home
Orbimed Advisors reported a 10.7% stake in Passage BIO PASG · 6,650,000 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 10.7%
- Last report
- 12% · filed 24/12/26
- Shares held
- 6,650,000 sh
- Class
- Common Stock
- Stock
- Passage BIO PASG
- Holder
- Orbimed Advisors
- Event date
- 25/04/22
- Filed
- 25/04/25
10.7% stake · −1.3pp from the last report
- Stake
- 10.7%
- Last report
- 12%
- Since last report
- −1.3pp
Passage BIO trades, last 26 weeks
What else happened in Passage BIO around then
Filed or reported within 30 days of the trade day · 25/03/23~25/05/22Orbimed Advisors's other 5% stake reports
- Orbimed Advisors
5% stakeElectra Therapeutics
5% stakeElectra Therapeutics
ETRA
11% stake
6,885,170 sh
11% stake
Filed 09/25
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
13.5% stake
12,175,159 sh
13.5% stake
Filed 09/10
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
17.2% stake
12,175,159 sh
17.2% stake
Filed 08/18
- Orbimed Advisors
5% stakeBlossomHill Therapeutics
5% stakeBlossomHill Therapeutics
BLSM
8.9% stake
2,714,279 sh
8.9% stake
Filed 08/18
- Orbimed Advisors
5% stakeWhitehawk Therapeutics
5% stakeWhitehawk Therapeutics
WHWK
7.3% stake
3,934,296 sh
7.3% stake
Filed 08/14
